Stock MGRC MALAYSIAN GENOMICS RESOURCE CENTRE
Add to a list
To use this feature you must be a member
Log inSign up

Financials Malaysian Genomics Resource Centre

Equities

MGRC

MYQ0155OO000

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
0.45 MYR +9.76% Intraday chart for Malaysian Genomics Resource Centre +11.11% +1.12%
05-07 Malaysian Genomics Resource, Twistcode Technologies In Bioinformatics Tie-Up Talks MT
04-29 Malaysian Genomics Resource Centre Berhad Announces Aswath A/L Ramakrishnan, Independent and Non Executive Director Was Not Reelected by Shareholders At the Annual General Meeting CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 24.32 41.92 105.6 144.1 99.61 61.06
Enterprise Value (EV) 1 34.53 54.86 99.5 134.4 80.72 55.67
P/E ratio -5.36 x -10.9 x 6.18 x -29.1 x 13.1 x -3.77 x
Yield - - - 1.56% - -
Capitalization / Revenue 0.93 x 1.51 x 111 x 80.8 x 3.51 x 6.38 x
EV / Revenue 1.32 x 1.98 x 105 x 75.4 x 2.85 x 5.81 x
EV / EBITDA -11.8 x -30.9 x -16.5 x -33 x 11.8 x -3 x
EV / FCF -5.87 x -39.3 x -44.8 x -26.9 x -22.5 x -
FCF Yield -17% -2.54% -2.23% -3.72% -4.45% -
Price to Book 1.23 x 2.63 x 10.3 x 7.67 x 2.56 x 2.73 x
Nbr of stocks (in thousands) 103,510 103,510 103,510 124,210 130,210 137,210
Reference price 2 0.2350 0.4050 1.020 1.160 0.7650 0.4450
Announcement Date 19/10/18 09/10/19 30/10/20 29/10/21 25/10/22 29/03/24
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 26.16 27.73 0.9513 1.784 28.36 9.574
EBITDA 1 -2.936 -1.774 -6.022 -4.068 6.822 -18.57
EBIT 1 -3.907 -2.924 -6.056 -4.335 6.024 -19.92
Operating Margin -14.94% -10.54% -636.61% -243.08% 21.24% -208.08%
Earnings before Tax (EBT) 1 -4.379 -3.516 -6.442 -4.293 6.182 -20
Net income 1 -4.535 -3.84 17.1 -4.293 7.21 -19.05
Net margin -17.34% -13.85% 1,797.49% -240.7% 25.42% -198.96%
EPS 2 -0.0438 -0.0371 0.1652 -0.0399 0.0586 -0.1181
Free Cash Flow 1 -5.881 -1.394 -2.221 -5.001 -3.589 -
FCF margin -22.48% -5.03% -233.41% -280.39% -12.66% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - 0.0182 - -
Announcement Date 19/10/18 09/10/19 30/10/20 29/10/21 25/10/22 29/03/24
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 10.2 12.9 - - - -
Net Cash position 1 - - 6.08 9.66 18.9 5.39
Leverage (Debt/EBITDA) -3.474 x -7.295 x - - - -
Free Cash Flow 1 -5.88 -1.39 -2.22 -5 -3.59 -
ROE (net income / shareholders' equity) -20.6% -21.5% -49.1% -30.5% 25.3% -
ROA (Net income/ Total Assets) -6.21% -4.69% -15.7% -16% 11.6% -
Assets 1 73.01 81.79 -108.6 26.83 61.92 -
Book Value Per Share 2 0.1900 0.1500 0.1000 0.1500 0.3000 0.1600
Cash Flow per Share 2 0.0700 0.0400 0.0600 0.1000 0.1700 0.0100
Capex 1 0.94 2.21 0.35 3.96 1.33 0.4
Capex / Sales 3.59% 7.99% 36.91% 222.18% 4.69% 4.13%
Announcement Date 19/10/18 09/10/19 30/10/20 29/10/21 25/10/22 29/03/24
1MYR in Million2MYR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
MALAYSIAN GENOMICS RESOURCE CENTRE Stock Malaysian Genomics Resource Centre
+1.12% 11.87M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.58% 8.44B
RADNET, INC. Stock RadNet, Inc.
+56.11% 3.96B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.78% 2.52B
SYNLAB AG Stock SYNLAB AG
-9.98% 2.44B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.91% 2.22B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-3.12% 1.98B
FLEURY S.A. Stock Fleury S.A.
-19.73% 1.58B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.30% 1.3B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+2.19% 1.05B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. MGRC Stock
  4. Financials Malaysian Genomics Resource Centre